Navigation Links
ReShape Medical Announces Initiation of U.S. Clinical Study for Weight Loss
Date:3/3/2010

SAN CLEMENTE, Calif., March 3 /PRNewswire/ -- ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss.  The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery. The ReShape device occupies existing space in the stomach to reduce its capacity for food.  The balloons remain in place for six-months and are then removed.

The first U.S. study participant received the ReShape Balloons Treatment at The N.E.W. Program in Newport Beach, Calif., under the care of Brian Quebbemann, M.D., FACS, and Surgical Director of The N.E.W. Program.  "At 6'2" and 263 pounds, this 31-year old man did not qualify for bariatric surgery, and had exhausted his efforts with diets that didn't work," said Dr. Quebbemann.  

Dr. Quebbemann added, "Countless Americans have grown beyond a healthy weight and struggle with conventional methods of weight loss, but can't or won't undergo surgery.  This group is ideally suited for a non-surgical weight loss treatment such as the ReShape device being evaluated in this study."

"We are very pleased to initiate the U.S. IDE clinical study to evaluate the safety and efficacy of this emerging weight loss treatment.  There are millions of Americans who have a BMI over 30, but there are few options available to help them with their weight loss," said Bill Murray, President and CEO of ReShape Medical, Inc.  "We are pioneering the next-generation weight loss solution."

About ReShape Medical, Inc.

ReShape Medical is a development-stage medical device manufacturer headquartered in Southern California. The company is focused on the development of a non-surgical weight loss device that can be used as an aid in the treatment of obese or overweight patients.  

CAUTION--Investigational device.  Limited by United States law to investigational use.

For more information, please visit www.reshapemedical.com.  

SOURCE ReShape Medical, Inc.

Back to top

RELATED LINKS
http://www.reshapemedical.com

'/>"/>

SOURCE ReShape Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017  Interpace Diagnostics Group, Inc. ... fully integrated commercial company that provides clinically useful ... that it has entered into agreements to successfully ... Shareholders ("RedPath") and concurrently terminate its royalty and ... secured debt to RedPath amounting to $9.34 million ...
(Date:3/23/2017)... DENVER , March 23, 2017  Drug ... pain medication misuse and deadly overdoses. A new ... Health Solutions, www.cordantsolutions.com , reports more detailed ... tests, which can potentially improve therapy adherence, patient ... The Cordant Comprehensive Oral fluid Rx Evaluation ...
(Date:3/23/2017)... , March 23, 2017 /PRNewswire/ - INVICTUS MD ... IVITF; FRA: 8IS) Invictus MD announces that AB Laboratories ... in its licensed production facility under the Access to ... Hamilton, Ontario . The ... in October 2016, is currently operating at half capacity, ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is ... making a huge impact on businesses and individual consumers alike. Laboratories can maximize ... have a value anywhere from $4 trillion to $11 trillion dollars by the year ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... serving the families and businesses of the Norwalk and Vermillion areas, celebrates ... Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer ...
(Date:3/23/2017)... ... 23, 2017 , ... The StayWell Company announced today that ... covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, ... excellent programs for the delivery and improvement of disease management and that meet ...
(Date:3/23/2017)... ... ... The TouchPoint Solution, home of Buzzies *, is boosting the Arizona economy ... change the way we interact with stress and live our day-to-day lives,” said Dr. ... December 2016, The TouchPoint Solution has sold more than $750,000 in product sales. The ...
(Date:3/23/2017)... ... 23, 2017 , ... After raising more than $1.135 million ($1,479,231 AUD) from ... pillow in crowdfunding history, has established a U.S. Headquarters in New York City, ... Americans. , “We’re excited to be operating on U.S. shores, where most of our ...
Breaking Medicine News(10 mins):